Podcast

Rapid Fire: Infectious Disease

Happy New Year Rounds Table Listeners!

We’re kicking off 2020 with an episode dedicated to all things Infectious Disease

Classic Rapid Fire format…4 papers…here we go!

  1. Can patients be with gram negative bacteremia be treated safely with shorter courses of antibiotics? (https://academic.oup.com/cid/article/69/7/1091/5237874) (00:20 – 05:22)
  2. What is the impact of RSV infections on older adults? (https://academic.oup.com/cid/article/69/2/197/5193205) (05:25 – 09:23)
  3. What role do single patient rooms have in reducing rates of health care associated infections? (https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2747870) (09:24 to 14:27)
  4. Using data mining techniques, how safe is the herpes zoster vaccine in the general population? (https://academic.oup.com/aje/article-abstract/188/7/1383/5486394) (14:28 – 19:50)

The Good Stuff

1.Why do Zebra’s have stripes? Might have something to do with minimizing bug bites!

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0210831

2.More on vaping; an update from the CDC

https://www.cdc.gov/mmwr/volumes/68/wr/mm6846e1.htm

 

Questions? Comments? Feedback? We’d love to hear from you. @roundstable

 

Leave a Comment

Your email address will not be published. Required fields are marked *

Authors

Michael Fralick

Co-director of the Rounds Table

Michael Fralick is a general internist at Mount Sinai Hospital in Toronto. He completed a Master of Science in Clinical Epidemiology at Harvard University, including a Research Fellowship in Health Policy at the Program On Regulation Therapeutics and Law (PORTAL). His PhD focused on the intersection between machine learning and pharmacoepidemiology.

John Fralick

Co-director

John Fralick is a general internist at Foothills Medical Centre in Calgary. He completed a Master of Science in Epidemiology at Queen’s University. He completed medical school at the University of Calgary and did his internal medicine training at the University of Toronto.

Republish this article

Republish this article on your website under the creative commons licence.

Learn more